Cancer Health Treatment Update
Surgery First for Colon Cancer?

Not so fast, according to a new study that found pre-surgery immunotherapy was effective for a common type of colorectal cancer.

Advertisement
Pioneering New Treatment Strategies for Melanoma
While exciting preclinical data has been generated, more research is needed before moving this work into clinical trials.
Elahere Antibody-Drug-Conjugate Leads to Remission of Ovarian Cancer

Results of the SORAYA study show antibody-drug conjugate produced remissions in one-third of patients with drug-resistant ovarian cancer.

As Pandemic-Era Medicaid Provisions Lapse, Millions Approach a Coverage Cliff

The federal government’s extra funding for states that kept people on Medicaid will end in the coming months.

Cancer Health Winter 2023
Check out our latest print edition!
Cancer Health now offers individual newsletters for people interested in specific cancer types. Get the latest cancer news tailored to your needs and interests delivered to your inbox. To update your preferences and start getting cancer-specific newsletters, please visit your personal preferences page.
Evusheld Is No Longer Effective for COVID PrEP

Monoclonal antibodies used to prevent COVID-19 in immunocompromised people aren’t active against new virus variants.

More News About COVID-19
See all Cancer Health's coverage of COVID-19, including how it affects people living with cancer. For more news about the SARS-CoV-2 coronavirus, visit our sister site, COVID Health.com.

You are receiving this email because you opted in at one of our websites. At your request, this message was sent to newsletter@newslettercollector.com by update@cancerhealth.com. Please remember to add update@cancerhealth.com to your email address book, so that these updates aren't blocked as spam.

To change your subscription information and preferences, please visit your personal preferences page. Or you can unsubscribe completely from this list.

To forward this message, please do not use the forward button of your email application, because this message was made specifically for you only. Instead use the forward page in our newsletter system.

Did you receive this email from a friend? You can subscribe and you will receive our next newsletter directly to your inbox.

Our mailing address is:

Smart + Strong
157 Columbus Avenue, Suite 525
New York, NY 10023

Add us to your address book

Copyright (C) 2023 Smart + Strong 157 Columbus Avenue, Suite 525 New York, NY 10023 USA All rights reserved.
Terms Of Use and Your Privacy.